ResearcherMayo ClinicNo recent work listed
Michael G. Sarr
Matched on ORCID iD 0000-0002-7793-152X; OpenAlex author ID A5071291870, A5107929241. Sources: ClinicalTrials.gov.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 1
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2001: 1 trial · 2002: none · 2003: none · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: 3 papers · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper
Papers 6
- Neoadjuvant therapy versus upfront resection for clinically "resectable" pancreatic cancer: The debate continues. Co-author DOI 10.1016/j.surg.2020.09.031↗
- Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer. Co-author DOI 10.1097/sla.0b013e318275b7e5↗
- Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. Last author DOI 10.1007/s11605-012-1853-2↗
- Suicide in patients with pancreatic cancer. Last author DOI 10.1002/cncr.25428↗
- Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to … Co-author DOI 10.1016/j.jamcollsurg.2011.04.003↗
- Inflammation-related gene variants as risk factors for pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-11-0264↗
Trials 1
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- K.E. Behrns · 1 shared paper, 2020 · strength 0.24
- Kaye M. Reid–Lombardo · 3 shared papers, 2011–2013 · strength 0.10
- Paper Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected… DOI 10.1097/sla.0b013e318275b7e5↗
- Paper Inflammation-related gene variants as risk factors for pancreatic cancer. DOI 10.1158/1055-9965.epi-11-0264↗
- Paper Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. DOI 10.1007/s11605-012-1853-2↗
- Brooke L. Fridley · 2 shared papers, 2011–2013 · strength 0.07
- Gloria M. Petersen · 2 shared papers, 2011–2013 · strength 0.07
- Michael B. Farnell · 2 shared papers, 2011–2012 · strength 0.06
- Kiran Kalyan Turaga · 1 shared paper, 2011 · strength 0.03
- Mokenge Peter Malafa · 1 shared paper, 2011 · strength 0.03
- Florencia G. Que · 1 shared paper, 2012 · strength 0.03
- Marianne Huebner · 1 shared paper, 2012 · strength 0.03
- Rui Qin · 1 shared paper, 2012 · strength 0.03
- Michael L. Kendrick · 1 shared paper, 2012 · strength 0.03
- Thomas Schnelldorfer · 1 shared paper, 2011 · strength 0.03
- Joshua A. Waters · 1 shared paper, 2011 · strength 0.03
- Keith D. Lillemoe · 1 shared paper, 2011 · strength 0.03
- Christian Max Schmidt · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.